Randomised controlled trial of patient controlled sedation for colonoscopy: entonox vs target controlled infusion of propofol

ISRCTN ISRCTN65879800
DOI https://doi.org/10.1186/ISRCTN65879800
Secondary identifying numbers N0084178528
Submission date
28/09/2007
Registration date
28/09/2007
Last edited
24/04/2012
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Surgery
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Not provided at time of registration

Contact information

Mr Sushil Maslekar
Scientific

Castle Hill Hospital
Castle Road
Cottingham
HU16 5JQ
United Kingdom

Study information

Study designRandomised controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Hospital
Study typeTreatment
Participant information sheet Not available in web format, please use the contact details below to request a patient information sheet
Scientific title
Study objectivesDoes patient controlled sedation using target controlled infusion of propofol provide an effective pain relief as that using entonox?
Ethics approval(s)Not provided at time of registration
Health condition(s) or problem(s) studiedSurgery: Analgesia
InterventionProspective RCT involving all patients undergoing elective colonoscopy at the Endoscopy Suite, Castle Hill Hospital.
Intervention typeDrug
Pharmaceutical study type(s)
PhaseNot Specified
Drug / device / biological / vaccine name(s)entonox, propofol
Primary outcome measurePain score on the visual analogue scale
Secondary outcome measuresPatient comfort, completion rate, time taken and complications, time to discharge and time for return of psychomotor function.
Overall study start date18/10/2005
Completion date30/10/2006

Eligibility

Participant type(s)Patient
Age groupNot Specified
SexBoth
Target number of participants20
Key inclusion criteriaAll patients of both sexes undergoing elective colonoscopy will be recruited.
Key exclusion criteriaPatients with chronic pulmonary disease, history of colonic resection, intolerance to any of the drugs, unwilling to enter trial, ASA class IV, allergy to soybeans, eggs, history of seizure disorder, sleep apnoea, or difficult intubation, a short thin neck or the inability to open mouth widely.
Date of first enrolment18/10/2005
Date of final enrolment30/10/2006

Locations

Countries of recruitment

  • England
  • United Kingdom

Study participating centre

Castle Hill Hospital
Cottingham
HU16 5JQ
United Kingdom

Sponsor information

Record Provided by the NHSTCT Register - 2007 Update - Department of Health
Government

The Department of Health, Richmond House, 79 Whitehall
London
SW1A 2NL
United Kingdom

Phone +44 (0)20 7307 2622
Email dhmail@doh.gsi.org.uk
Website http://www.dh.gov.uk/Home/fs/en

Funders

Funder type

Government

The North and South Bank Research and Development Consortium (UK), NHS R&D Support Funding

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results 01/01/2011 Yes No